AI and predictive analytics are moving higher up the agenda for pharmaceutical supply chain leaders, but scaling them successfully still depends on some familiar fundamentals: data quality, supply chain visibility, the right use cases and organisational readiness.

At LogiPharma Asia 2026, we caught up with Brett Marshall of SuppLexis, Amy Xue of Dishman Carbogen Amcis Europe and Belinda Ang of Roche to revisit the findings of our 2026 Benchmarking Report and explore what has changed since the research was published.

Their discussion looks at what is still holding back AI adoption in pharma supply chains, why insight does not always translate into action, and what leaders should prioritise as they shape their 2027 pharmaceutical supply chain strategy.

Watch the full onsite interview below for their perspectives on AI, predictive analytics, data strategy, digital transformation and supply chain resilience.